DX
Insider
Diyong Xu
DirectorDiyong Xu (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Q32 Bio Inc. (QTTB). Across 1 priced purchase filing, the average 21-session return was +14.3% from execution and +17.7% from disclosure (delay-adjusted; derived). The largest single filing was $15.0M of QTTB (1,875,000 sh across 2 lots, as filed), executed May 28.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+14.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+17.7%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$15.0M
shares × price, as filed
Last traded
May 28
Filed Jun 1
Median ADV $23.2M across their filed names
Open performance→Volume by month
Buys $15.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
QTTBRecent filings
QTTBPURCHASE
Q32 Bio Inc.
View filing →
$15.0M1,875,000 sh across 2 lots
Exec May 28
Filed Jun 1 · 9:15 PM ET